Cargando…
Huntington’s Disease Clinical Trials Corner: February 2018
In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTT(RX) trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-H...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836398/ https://www.ncbi.nlm.nih.gov/pubmed/29480210 http://dx.doi.org/10.3233/JHD-189001 |
| _version_ | 1783303957588738048 |
|---|---|
| author | Rodrigues, Filipe B. Wild, Edward J. |
| author_facet | Rodrigues, Filipe B. Wild, Edward J. |
| author_sort | Rodrigues, Filipe B. |
| collection | PubMed |
| description | In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTT(RX) trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-HD2 (NCT03225846), and cover one recently finished trial: the FIRST-HD deutetrabenazine trial (NCT01795859). |
| format | Online Article Text |
| id | pubmed-5836398 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | IOS Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58363982018-03-07 Huntington’s Disease Clinical Trials Corner: February 2018 Rodrigues, Filipe B. Wild, Edward J. J Huntingtons Dis Clinical Trials Corner In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTT(RX) trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-HD2 (NCT03225846), and cover one recently finished trial: the FIRST-HD deutetrabenazine trial (NCT01795859). IOS Press 2018-02-24 /pmc/articles/PMC5836398/ /pubmed/29480210 http://dx.doi.org/10.3233/JHD-189001 Text en © 2018 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Clinical Trials Corner Rodrigues, Filipe B. Wild, Edward J. Huntington’s Disease Clinical Trials Corner: February 2018 |
| title | Huntington’s Disease Clinical Trials Corner: February 2018 |
| title_full | Huntington’s Disease Clinical Trials Corner: February 2018 |
| title_fullStr | Huntington’s Disease Clinical Trials Corner: February 2018 |
| title_full_unstemmed | Huntington’s Disease Clinical Trials Corner: February 2018 |
| title_short | Huntington’s Disease Clinical Trials Corner: February 2018 |
| title_sort | huntington’s disease clinical trials corner: february 2018 |
| topic | Clinical Trials Corner |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836398/ https://www.ncbi.nlm.nih.gov/pubmed/29480210 http://dx.doi.org/10.3233/JHD-189001 |
| work_keys_str_mv | AT rodriguesfilipeb huntingtonsdiseaseclinicaltrialscornerfebruary2018 AT wildedwardj huntingtonsdiseaseclinicaltrialscornerfebruary2018 |